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Ghrelin, a peptide hormone produced mainly in the stomach, has emerged as an important modulator of the inﬂammatory
responses that are of signiﬁcance to the maintenance of gastric mucosal integrity. Here, we report on the role of ghrelin in
controlling the apoptotic processes induced in gastric mucosal cells by H. pylori lipopolysaccharide (LPS). The countering eﬀect
of ghrelin on the LPS-induced mucosal cell apoptosis was associated with the increase in constitutive nitric oxide synthase (cNOS)
activity, and the reduction in caspase-3 and inducible nitric oxide synthase (NOS-2). The loss in countering eﬀect of ghrelin on
the LPS-induced changes in apoptosis and caspase-3 activity was attained with Src kinase inhibitor, PP2, as well as Akt inhibitor,
SH-5, and cNOS inhibitor, L-NAME. Moreover, the eﬀect of ghrelin on the LPS-induced changes in cNOS activity was reﬂected in
the increased cNOS phosphorylation that was sensitive to SH-5. Furthermore, the ghrelin-induced up-regulation in cNOS activity
was associated with the increase in caspase-3 S-nitrosylation that was susceptible to the blockage by L-NAME. Therefore, ghrelin
protection of gastric mucosal cells against H. pylori LPS-induced apoptosis involves Src/Akt-mediated up-regulation in cNOS
activation that leads to the apoptotic signal inhibition through the NO-induced caspase-3 S-nitrosylation.
1.Introduction
Lipopolysaccharide (LPS), a component of the outer mem-
brane of Gram-negative bacterium H. pylori colonizing
the gastric mucosa, is recognized as a potent endotoxin
responsible for eliciting mucosal inﬂammatory responses
that characterize gastritis and duodenal ulcers [1, 2]. Indeed,
the gastric mucosal response to H. pylori LPS or associated
with gastritis caused by H. pylori infection is manifested
by the increase in proinﬂammatory cytokine production,
disturbances in nitric oxide generation system, and a massive
rise in epithelial cell apoptosis [1, 3, 4].
Of the three nitric oxide synthase (NOS) isozymes
responsible for NO generation, the two expressed consti-
tutively (cNOS) are Ca2+-dependent and provide precise
pulses of NO for a ﬁne modulation of the cellular processes,
including the inhibition of apoptogenic signals [5, 6]. The
inducible isoform of NOS, known as iNOS or NOS-2, is
Ca2+-independentand,onceinduced,providesahighoutput
of NO generation for host defense. However, its massive and
sustained activation may have also cytotoxic consequences,
causing transcriptional disturbances and the induction of
apoptosis through the activation of a group of aspartate-
speciﬁc cysteine proteases, caspases [6, 7].
Based on their function, the caspase proteases are
categorized into initiator and executioner subtypes [6, 8].
The implementation of the apoptotic program requires the
participation of both subtypes of caspases, the initiator
caspases (caspases-8, -9, and -10), which activate the execu-
tioner caspases (caspses-3, -6, and -7), which in turn cleave
the targeted intracellular substrates [8, 9]. The activation of
executioner caspases is recognized as an irreversible commit-
ment to the execution phase of apoptosis characterized by
cytoplasmic shrinkage, breakdown of nuclear envelope, con-
densation of chromatin structure, and DNA fragmentation
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A substantial volume of data indicates that the propaga-
tion of apoptogenic signal is inﬂuenced by intracellular NO
production [6, 7, 10]. Indeed, NO is capable of aﬀecting the
function of many proteins by reacting with their cysteine
amino acid residue to form S-nitrosothiols, and all caspases
are known to contain a critical cysteine at the catalytic site
that is a target of S-nitrosylation [7, 10, 11]. Moreover,
NO has been shown to possess both the pro- and anti-
apoptotic eﬀects depending on cell and type of the NOS
isozyme involved. In general, S-nitrosylation resulting form
sustained NOS-2 activation appears to have proapoptotic
eﬀect, while the low level of NO production by cNOS is
believed to be a transient cell-signaling event that has anti-
apoptotic eﬀect [5, 7]. Indeed, the inhibition of cNOS has
been reported to potentiate ischemia-reperfusion-induced
myocardial apoptosis via a caspase-3-dependent pathway,
while the inhibition of apoptosis was attained by caspase-3
S-nitrosylation [7, 12].
Recent advances into the nature of factors involved in the
maintenance of gastric mucosal integrity that are capable of
inﬂuencing the extent of mucosal inﬂammatory responses
have resulted in identiﬁcation of ghrelin [13]. This 28-amino
acid peptide hormone, produced mainly in the stomach,
has emerged as an important modulator of the processes
of gastric mucosal repair, protection against acute mucosal
injury by ethanol, and the control of local inﬂammatory
responses to bacterial infection [14–16]. Moreover, ghrelin
has been identiﬁed as an important regulator of the mucosal
NOS system responsible for NO production [17, 18].
In this study, we investigated the inﬂuence of ghrelin
on the apoptotic processes induced in gastric mucosal cells
by H. pylori lipopolysaccharide. Our data revealed that
ghrelin protection of the mucosal cells against the LPS-
induced apoptosis results from cNOS-derived NO inhibition
of caspase-3 activity through S-nitrosylation.
2.MaterialsandMethods
2.1. Mucosal Cell Incubation. The gastric mucosal cells,
collected by scraping the mucosa of freshly dissected rat
stomachs with a blunt spatula, were suspended in ﬁve
volumes of ice-cold Dulbecco’s modiﬁed (Gibco) Eagle’s
minimal essential medium (DMEM), supplemented with
fungizone (50μg/mL), penicillin (50U/mL), streptomycin
(50μg/mL), and 10% fetal calf serum, and gently dispersed
by trituration with a syringe, and settled by centrifugation
[19]. Following rinsing, the cells were resuspended in the
medium to a concentration of 2 × 107 cell/mL, transferred
in 1mL aliquots to DMEM in culture dishes, and incubated
under 95% O2,5 %C O 2, and atmosphere at 37◦Cf o r1 6h
in the presence of 0–200ng/mL of H. pylori LPS [20].
In the experiments evaluating the eﬀect of ghrelin (rat,
Sigma), cNOS inhibitor, L-NAME, iNOS inhibitor, 1400W,
Src inhibitor, PP2, Akt inhibitor, SH-5 (Calbiochem), and
ascorbate (Sigma), the cells were ﬁrst preincubated for 30
minuteswiththeindicateddoseoftheagentorvehiclebefore
theadditionoftheLPS[20].Theviabilityofcellpreparations
before and during the experimentation, assessed by Trypan
blue dye exclusion assay [20], was greater than 97%.
2.2. Apoptosis and Caspase-3 Activity Assay. For apoptotic
measurements, the cells from the control and various
experimental conditions were settled by centrifugation,
and incubated in the lysis buﬀer (Boehringer Mannheim).
Following centrifugation, the supernatant containing the
cytoplasmic histone-associated DNA fragments was reacted
with immobilized antihistone antibody. After washing, the
retainedcomplexwasreactedwithanti-DNAperoxidase,and
probed with ABTS reagent for spectrophotometric quantiﬁ-
cation [20]. Caspase-3 activity assays were conducted with
using Quanti Zyme assay system (Biomol). The cells from
thecontrolandexperimentaltreatmentswereincubatedwith
the lysis buﬀer according to the manufacturer’s instruction,
followed by centrifugation at 10,000 ×g for 10min. The
aliquots of the resulting cytosolic fraction were incubated
with 50μM of Ac-DEVD-pNA substrate for 1h at 37oC, and
the caspase-3 activity were measured spectrophotometrically
[19].
2.3. cNOS and NOS-2 Activity Assay. Nitric oxide synthase
activities of cNOS and NOS-2 enzymes in the gastric
mucosal cells was measured by monitoring the conversion
of L-[3H]arginine to L-[3H]citrulline using NOS-detect kit
(Stratagene). The cells from the control and experimental
treatments were homogenized in a sample buﬀer containing
either 10mM EDTA (for NOS-2) or 6mM CaCl2 (for
cNOS), and centrifuged [21]. The aliquots of the resulting
supernatant were incubated for 30 minutes at 25◦C in the
presence of 50μCi/mL of L-[3H]arginine, 10mM NAPDH,
5μM tetrahydrobiopterin, and 50mM Tis-HCl buﬀer, pH
7.4, in a ﬁnal volume of 250μl. Following addition of
stop buﬀer and Dowex-50 W (Na+)resin, the mixtures were
transferred to spin cups and centrifuged, and the formed L-
[3H]citrulline contained in the ﬂow through was quantiﬁed
by scintillation counting.
2.4. Caspase-3 S-Nitrosylation. A biotin-switch procedure
was employed to assess caspase-3 protein S-nitrosylation
[22, 23]. The mucosal cells, treated with ghrelin (0.5μg/ml)
or L-NAME (300μM)+ghrelin and incubated for 16h in the
presence of 100ng/ml of H. pylori LPS, were lysed in 0.2mL
of HEN lysis buﬀer, pH 7.7, and the unnitrosylated thiol
groups were blocked with S-methyl methanethiosulfonate
reagent [23]. The proteins were precipitated with acetone,
resuspended in 0.2mL of HEN buﬀer containing 1% SDS,
and subjected to targeted nitrothiol group reduction with
sodium ascorbate (100mM). The free thiols were then
labeled with biotin and the biotinylated proteins were recov-
ered on streptavidin beads. The formed streptavidin bead-
protein complex was washed with neutralization buﬀer, and
the bound proteins were dissociated from streptavidin beads
with 50μlo fe l u t i o nb u ﬀer (20mM HEPES, 100mM NaCl,
1mM EDTA, pH 7.7) containing 1% 2-mercaptoethanol
[23]. The obtained proteins were then analyzed by Western
blotting.
2.5. Western Blot Analysis. The mucosal cells, collected by
centrifugation, were resuspended for 30 minutes in ice-cold
lysis buﬀer [17], and following brief sonication the lysatesMediators of Inﬂammation 3
were centrifuged at 12,000g for 10 minutes, and the
supernatants were subjected to protein determination using
BCA protein assay kit (Pierce). The samples, including those
subjected to biotin-switch procedure, were then resuspended
in loading buﬀer, boiled for 5 minutes, and subjected to
SDS-PAGE using 30μg protein/lane. The separated proteins
were transferred onto nitrocellulose membranes, blocked
with 5% skim milk, and probed with the antibody against
phosphorylated protein at 4◦C for 16h. After 1h of incuba-
tion with the horseradish peroxidase-conjugated secondary
antibody,thephosphorylatedproteinswererevealedusingan
enhanced chemiluminescence. Membranes were stripped by
incubation in 1M Tris-HCl (pH 6.8), 10% SDS, and 10mM
dithiotreitol for 30 minutes at 55◦C ,a n dr e p r o b e dw i t h
antibody against proteins of interest. Immunoblotting was
performed using speciﬁc antibodies directed against cNOS,
phospho-cNOS (Calbiochem), and caspase-3 (Sigma).
2.6. Data Analysis. All experiments were carried out using
duplicate sampling, and the results are expressed as means
± SD. Analysis of variance (ANOVA) was used to determine
signiﬁcance and the signiﬁcance level was set at P<. 05.
3. Results
The role of ghrelin in modulation of the apoptotic processes
associated with H. pylori infection was investigated using
rat gastric mucosal cells exposed to H. pylori key virulence
factor, LPS. Employing apoptotic DNA fragmentation assay
in conjunction with the measurements of caspase-3 activity,
we demonstrated that the LPS caused a dose-dependent
increase in gastric mucosal cell apoptosis and caspase-3
activity, which at 100μg/ml LPS reached respective values of
4.4- and 13.5-fold over that of controls (Figure 1). Moreover,
we found that the LPS at 100μg/ml also caused a 19.8-fold
increase in gastric mucosal cell NOS-2 activity, while the
cNOS activity showed a 4.3-fold decrease (Figure 2).
Preincubation of the mucosal cells with ghrelin led
to a concentration-dependent decrease in the LPS-induced
changes, and at the optimal concentration of 0.5μg/ml
resulted in a 68.7% drop in apoptosis and a 78% reduction
in caspase-3 activity (Figure 3), as well as a 90.2% decrease
in NOS-2 activity (Figure 4). However, the activity of gastric
mucosal cell cNOS increased by a 77.5% (Figure 4). Further,
we found that signiﬁcant loss in the preventive eﬀect to
ghrelin on the LPS-induced changes in the mucosal cell
apoptosis and caspase-3 activity occurred with Src kinase
inhibitor, PP2, as well as Akt inhibitor, SH-5, and cNOS
inhibitor, L-NAME, while selective NOS-2 inhibitor, 1400W,
had no eﬀect (Figure 5). Moreover, the eﬀects PP2 and SH-
5, like that of L-NAME, were reﬂected in the inhibition of
ghrelin-induced cNOS activity (Figure 6).
To gain additional leads into the mechanism of ghrelin-
induced signaling resulting in up-regulation in gastric
mucosal cell cNOS activity, we examined the eﬀect of
ghrelin on the cNOS phosphorylation. As cNOS is known
to undergo a rapid posttranslational activation through
phosphorylation at Ser1177 by kinase Akt [17, 18], the
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Figure 1: Eﬀect of H. pylori LPS on rat gastric mucosal cell
apoptosis and caspase-3 activity. The cells were treated with the
indicated concentrations of the LPS and incubated for 16h. Values
represent the means ± SD of ﬁve experiments.
∗P <. 05 compared
with that of control (LPS, 0).
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Figure 2: Eﬀect of H. pylori LPS on the expression of inducible
(NOS-2) and constitutive (cNOS) nitric oxide synthase activities in
rat gastric mucosal cells. The cells were treated with the indicated
concentrations of the LPS and incubated for 16h. Values represent
the means ± SD of ﬁve experiments.
∗P <. 05 compared with that
of control (LPS, 0).
cells prior to ghrelin incubation were pretreated with Akt
inhibitor, SH-5, and the lysates were examined for cNOS
activation using antibody directed against total cNOS and
phosphorylated cNOS (pcNOS). As shown in Figure 7, the
countering eﬀect of ghrelin on the LPS-induced changes in
the mucosal cell cNOS activity was reﬂected in a marked
increase in the enzyme protein phosphorylation, while the
suppression of ghrelin eﬀect by Akt inhibitor, SH-5, was
manifested in a drop in the cNOS phosphorylation.
Since NO is known to exert the modulatory eﬀect
on the apoptotic processes through caspase cysteine S-
nitrosylation [6, 7, 12], we next analyzed the inﬂuence4 Mediators of Inﬂammation
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Figure3:EﬀectofghrelinonH.pyloriLPS-inducedgastricmucosal
cell apoptosis and the activity of caspase-3. The cells, preincubated
with the indicated concentrations of ghrelin, were treated with the
LPS at 100ng/mL and incubated for 16h. Values represent the
means ± SD of ﬁve experiments.
∗P <. 05 compared with that of
control.
∗∗P <. 05 compared with that of LPS alone.
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Figure 4: Eﬀect of ghrelin on H. pylori LPS-induced expression
of NOS-2 and cNOS activities in gastric mucosal cells. The cells,
preincubated with the indicated concentrations of ghrelin, were
treated with the LPS at 100 ng/mL and incubated for 16h. Values
represent the means ± SD of ﬁve experiments.
∗P <. 05 compared
with that of control.
∗∗P <. 05 compared with that of LPS alone.
of ghrelin on the mucosal cell caspase-3 S-nitrosylation.
The results revealed that ghrelin countering eﬀect on the
LPS-induced up-regulation in the mucosal cell apoptosis
and caspase-3 activity was susceptible to suppression by
ascorbate (Figure 5), which is in keeping with well-known
susceptibility of S-nitrosylated proteins to this reducing
agent [17, 22, 23]. Furthermore, Western blot analysis of
the cell lysates subjected to biotin-switch procedure and
probingwithantibodyagainstcaspase-3revealedthatghrelin
countering eﬀect on the LPS-induced up-regulation in the
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Figure 5: Eﬀect of nitric oxide synthase inhibitors on the ghrelin
(Gh-) induced changes in gastric mucosal cell apoptosis and the
activity of caspase-3. The cells, preincubated with 30μM PP2,
300μM L-NAME (LN), 20μM 1400W (14W), 300μMa s c o r b a t e
(As), or 20μM SH-5 (SH), were treated with Gh at 0.5μg/mL and
incubated for 16h in the presence of 100ng/mL of H. pylori LPS.
Values represent the means ± SD of ﬁve experiments.
∗P <. 05
compared with that of control.
∗∗P <. 05 compared with that of
LPS alone.
∗∗∗P <. 05 compared with that of Gh+LPS.
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Figure 6: Eﬀect of nitric oxide synthase inhibitors on the ghrelin
(Gh-) induced changes in cNOS activity in gastric mucosal cell
exposed to H. pylori LPS. The cells, preincubated with 30μM PP2,
300μM L-NAME (LN), 20μM 1400W (14W), or 20μMS H - 5
(SH), were treated with Gh at 0.5μg/mL and incubated for 16h
in the presence of 100ng/mL LPS. Values represent the means ±
SD of ﬁve experiments.
∗P <. 05 compared with that of control.
∗∗P <. 05 compared with that of LPS alone.
∗∗∗P <. 05 compared
with that of Gh+LPS.
caspase-3 activity was manifested in the increase in caspase-
3 S-nitrosylation. Preincubation with L-NAME on the other
handcausedtheblockageintheghrelin-inducedcaspase-3S-
nitrosylation (Figure 8). Collectively, these data demonstrate
that ghrelin protection of gastric mucosal cells against
H. pylori LPS-induced apoptosis involves cNOS-induced
suppression of caspase-3 activity through S-nitrosylation.Mediators of Inﬂammation 5
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Figure 7: Eﬀect of Akt inhibitor, SH-5 (SH), on ghrelin- (Gh-)
induced cNOS phosphorylation in gastric mucosal cells exposed
to H. pylori LPS. The cells were treated with Gh (0.5μg/mL)
or SH (20μM)+Gh and incubated for 16h in the presence of
100ng/mlLPS.CelllysateswereresolvedonSDS-PAGE,transferred
to nitrocellulose, and probed with phosphorylation-speciﬁc cNOS
(pcNOS) antibody, and after stripping reprobed with anti-cNOS
antibody. The immunoblots shown are representative of three
experiments.
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Figure 8: Eﬀect of cNOS inhibitor, L-NAME (LN), on ghrelin-
(Gh-) induced caspase-3 S-nitrosylation in gastric mucosal cells
exposedtoH.pyloriLPS.ThecellsweretreatedwithGh(0.5μg/mL)
or LN (300μM)+Gh and incubated for 16h in the presence of
100ng/mL LPS. A portion of the cell lysates was processed by
biotin-switch procedure for protein S-nitrosylation and, along with
the reminder of the lysates, subjected to SDS-PAGE, transferred
to nitrocellulose, and probed with anti-caspase-3 antibody. The
immunoblots shown are representative of three experiments.
4. Discussion
Nitric oxide, a gaseous signaling molecule, is recognized
as an important eﬀe c t o ro faw i d ev a r i e t yo fr e g u l a t o r y
pathways that are of signiﬁcance to cellular survival and
the inﬂammatory responses to bacterial infection. More-
over, due to its high reactivity, NO is also capable of
aﬀecting the function of a number of proteins by reacting
with cysteine residues to form S-nitrosothiols [7, 10, 12].
Rapidly accumulating evidence suggests that, like posttrans-
lational modiﬁcation through phosphorylation, the protein
S-nitrosylation is a targeted and reversible posttranslational
modiﬁcation that regulates protein activity during cell
signaling [6, 7, 11]. Indeed, S-nitrosylation of mitochon-
drial protein thiols is known to block cell death after
glutathione depletion, and contributes to redox regulatory
activity and antiapoptotic function of thioredoxin, and S-
nitrosylation of a key executioner caspase, caspase-3, has
been implicated in the regulation of apoptotic processes
b yt h eN O Se n z y m ec o m p l e x[ 7, 10, 12, 24]. Moreover, it
became apparent that pro- or antiapoptotic eﬀects of NO-
induced S-nitrosylation depend upon the targeted protein
colocalization with the NOS-2 or cNOS isozyme system
[7, 10].
Hence, in keeping with recent evidence for the role
of ghrelin in controlling gastric mucosal inﬂammatory
responses through regulation of the mucosal NO production
[15–18], in the present study we examined the inﬂuence of
this peptide hormone on the apoptotic processes associated
with H. pylori infection. Using rat gastric mucosal cells
exposed to H. pylori k e yv i r u l e n c ef a c t o r ,L P S ,w ed e m o n -
strated that the LPS-induced enhancement in the mucosal
cell apoptosis and caspase-3 activity was associated with
a marked decrease in cNOS activity and up-regulation in
NOS-2. Further, our results revealed that the countering
eﬀect of ghrelin on the LPS-induced mucosal cell apoptosis
was reﬂected in the increase in the cNOS activity, and the
reduction in caspase-3 and NOS-2 activity. Moreover, a
signiﬁcantlossinthecounteringeﬀectofghrelinontheLPS-
induced changes in the mucosal cell apoptosis and caspase-3
activitywasattainedwithcNOSinhibitor, L-NAME,whereas
selective NOS-2 inhibitor, 1400W, had no eﬀect. These
ﬁndings are thus in keeping with the results of earlier studies
demonstrating that the proapoptotic eﬀects of H. pylori on
gastric epithelial cell integrity relay on NOS-2 participation
intheampliﬁcationofthecelldeathsignalingcascade[4,21].
The fact that the induced proapoptotic events were also
associated with a marked decrease in cNOS activity, while
the countering eﬀects of ghrelin were reﬂected in a decrease
in NOS-2 and up-regulation in cNOS activities, furthermore
attests to the modulatory inﬂuence of cNOS on the LPS-
induced apoptogenic signal propagation.
Further,wefoundthatthecountering eﬀectofghrelinon
the LPS-induced changes in gastric mucosal cell apoptosis
and caspase-3 activity were subject to suppression by Src
kinase inhibitor, PP2, as well as Akt inhibitor, SH-5; both of
which also abrogated the ghrelin-induced up-regulation in
cNOS activity. Hence, we concluded that ghrelin countering
eﬀect on the LPS-induced proapoptotic events occurs with
the involvement of Src-kinase-mediated cNOS activation
through Akt. Our assertion is supported by the data showing
that the countering eﬀect of ghrelin on the LPS-induced
changes in cNOS activity was reﬂected in the increase in
enzyme protein phosphorylation, while the suppression of
ghrelin eﬀect by Akt inhibitor, SH-5, was manifested in
a drop in cNOS phosphorylation. Indeed, recent reports
show that posttranslational regulation of cNOS activity
involves a rapid enzyme protein phosphorylation at the
critical Ser1177 with the participation of Src/Akt pathway,
and that ghrelin induces up-regulation in NO production
by the activation of Akt-mediated cNOS phosphorylation
[17, 18, 25].
A substantial volume of evidence implicates NO in the
regulation of apoptotic cell death through the modulation
of apoptogenic signals propagated by the caspase cascade [6,
7, 10]. Upon apoptotic stimulation, these cysteine aspartyl
proteases are known to undergo NO-induced targeted
S-nitrosylation with pro- or antiapoptotic consequences,
depending on subcellular localization and the proximity to6 Mediators of Inﬂammation
NOS-2 or cNOS isozyme system [10, 11]. In our study,
we assessed the inﬂuence of ghrelin on S-nitrosylation of
the key executioner caspase, caspase-3. We found that,
in keeping with well-known vulnerability of S-nitrosylated
proteinstoreductionbyascorbicacid[17,22,23],theghrelin
countering eﬀect on H. pylori LPS-induced up-regulation in
gastric mucosal cell caspase-3 activity showed susceptibility
to the suppression by ascorbate. Moreover, Western blot
analysis of the mucosal cell lysates subjected to biotin-switch
procedurerevealedthatghrelincounteringeﬀectontheLPS-
induced up-regulation in caspase-3 activity was reﬂected
in the increased caspse-3 S-nitrosylation. The suppression
of ghrelin eﬀect on NO production with cNOS inhibitor,
L-NAME, led to the blockage of caspase-3 S-nitrosylation,
thus supporting the role of cNOS-induced caspase-3 S-
nitrosylation in the mechanism of ghrelin protection against
H. pylori-induced gastric mucosal cell apoptosis.
In summary, we provide evidence that ghrelin is capa-
ble of gastric mucosal protection against H. pylori LPS-
induced apoptosis. The data suggest that the modulatory
eﬀect of ghrelin occurs with the involvement of Src/Akt
kinase-mediated up-regulation in cNOS activation through
phosphorylation, and that cNOS-mediated caspase-3 S-
nitrosylation induced by ghrelin plays an essential role in the
apoptotic signal cascade inhibition.
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